HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Onconova Therapeutics, Inc. (ONTX)
0.2802  -0.0027  (-0.95%) 10-21 04:18
Open: 0.2829 High: 0.2845
Pre.close: 0.2829 Low: 0.2733
Volume: 4,535,996 Ave vol: 20,734,924
52w High: 1.56 52w Low: 0.1
MA(50): 0.27 MA(200): 0.515
EPS: -0.243 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: https://www.onconova.com/
Market Cap (M): 51
Shares Out (M): 184
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. The company is headquartered in Newtown, Pennsylvania and currently employs 25 full-time employees. The firm operates through the identification and development of oncology therapeutics segment. The company is focused on discovering and developing small molecule drug candidates to treat cancer. The firm has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. The company has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The firm's lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.
Technical analysis
Overall: Underperform
MA: Bearish MACD: Bullish
KDJ: Bearish RSI: Bullish
Target 1: 0.42 Target 2: 0.51
Resist 1: 0.36 Resist 2: 0.44
Support 1: 0.23 Support 2: 0.19
Company key metrics
Revenue per Share: 0.1518
Net Income per Share: -1.4949
Cash per Share: 1.5799
Book Value per Share: 0.8046
Price to Sales: 2.3722
Price to Book Value: 0.4474
Earnings Yield: -4.1524
Dividend Yield: 0
Debt to Equity: 1.0454
Debt to Assets: 0.5111
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.